Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > 3RD QUARTERLY FINANCIALS ENDING 30-04-2023 SHOULD BE READY !
View:
Post by august202013 on Jun 13, 2023 2:30pm

3RD QUARTERLY FINANCIALS ENDING 30-04-2023 SHOULD BE READY !

BY NOW THE 3RD QUARTERLY FINANCIALS ENDING. APRIL, 30, 2023  ARE ALREADY READY WITH MM PENDING RELEASE BY FIRST WEEK OF JULY, 2023 BUT COULD BE WELL BEFORE JULY, 7, 2023.

HAVE TO BE PATIENT AND WAIT FOR THE RELEASE AND FACE WHAT EVER COMES OUT. NO MIRACLE EXPECTED AS THERE WAS NO HUGE DEMAND FOR COVID19 TEST KIT EVEN IN EUROPE FOR PERIOD FEBRUARY/MARCH/APRIL 2023. AS HAVE TO BE REALISTIC. ANY SUPRISES WOULD BE FROM REVEAL TP (SYPHILIS) WITH CE MARK IN EUROPE IN EARLY MARCH 2023 AND CLINICAL TRIAL IN SACHKETCHWEN  ALSO CONDUCTED IN BC IN APRIL, 2023.  AS SUCH COULD INCLUDE 2 MONTHS SALES FIGURE FROM THAT LINE.

HOPING FOR A SLIGHT DEFICIT WILL BE A PLUS MAYBE A GOOD BUY NOW PENDING FINANCIAL RELEASE BUT A HUGE DEFICIT WILL BE SOMBER MOOD AND HAVE TO BRACE FOR BIGGER DEFICIT FOR 4TH QUARTERLY UNLESS HC ISSUES A PO WHICH SHOULD THEN BE A BUY, 

MILLION DOLLAR QUESTION IS

IF HC (NOT BIG BROTHER) IS GOING TO?

LIKELIHOOD ?  

ANSWER IS BETTER THIS ROUND
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse